Defects in interferon (IFN) signaling that result in loss of expression of IFN-inducible proteins are associated with cellular immortalization, an important early event in the development of human cancer. Here we report that loss of IFN-inducible IFI 16 expression in human fibroblasts allows bypass of cellular senescence. We found that levels of IFI 16 mRNA and protein were higher in human old versus young fibroblasts and immortalization of fibroblasts with telomerase resulted in decreased expression of IFI 16. Moreover, overexpression of IFI 16 in immortalized fibroblasts strongly inhibited cell proliferation. Interestingly, knockdown of IFI 16 expression in fibroblasts inhibited p53-mediated transcription, downregulated p21 WAF1 expression, and extended the proliferation potential. Importantly, treatment of immortal cell lines with 5-aza-2 0 -deoxycytidine, an inhibitor of DNA methyltransferase, resulted in upregulation of IFI 16. Our observations support the idea that increased levels of IFI 16 in older populations of human fibroblasts contribute to cellular senescence.
Introduction
Human fibroblasts display a limited proliferation potential in vitro before they enter an irreversible cell growth arrest, defined as replicative or cellular senescence (Hayflick, 1965; Smith and Pereira-Smith, 1996) . Accumulating data suggest that the irreversible cell growth arrest associated with cellular senescence represents a major barrier, which cells must circumvent to become malignant (Campisi, 2001 (Campisi, , 2003 . Therefore, elucidations of the molecular mechanisms by which cells can bypass cellular senescence are critical to the understanding of development of human cancer.
p53 is presumed to sense dysfunctional telomeres as damaged DNA (Sharpless and DePinho, 2002) , whereupon it elicits the senescence response, at least in part, by increasing expression of p21 WAF1 ; p21 WAF1 in turn prevents the phosphorylation and inactivation of pRB. Levels of p21 WAF1 increase in human diploid fibroblasts (HDFs) and other cell types when cells approach cellular senescence (Sharpless and DePinho, 2002; Campisi, 2003) . Moreover, the loss of p21 WAF1 expression in HDFs results in an extension of their proliferative potential (Brown et al., 1997) .
Interferons (IFNs) are a family of cytokines (Sen and Lengyel, 1992) . The family includes type-I (IFN-a and -b) and type-II (IFN-g) IFNs. IFNs are potent inhibitors of cell growth both in vitro and in vivo and exhibit antitumor activity (Borden et al., 2000) . Of note, expression of both p53 (Takaoka et al., 2003) and p21 WAF1 (Sangfelt et al., 1999) is upregulated by IFNs. Because IFN-inducible proteins mediate the growth-inhibitory activities of IFNs (Stark et al., 1998) , it is important to define their role in the signaling pathways that contribute to senescenceassociated irreversible cell growth arrest.
Recent studies involving unbiased approaches have revealed that defects in IFN signaling are associated with immortalization of human cells (Shou et al., 2002; Untergasser et al., 2002; Kulaeva et al., 2003) . Although, these studies suggest a role for IFN-inducible proteins in cellular senescence, the particular IFNinducible proteins contributing to cellular senescence remain to be identified.
The Ifi200 gene family encodes a family of IFNinducible proteins Johnstone and Trapani, 1999; Asefa et al., 2004) . The family includes in mice Ifi202a, Ifi202b, Ifi203, Ifi204, and D3 genes; and in humans IFI16, MNDA, and AIM2 genes Wang et al., 1999) . The murine genes are located on the long arm of mouse chromosome 1 , which is syntenic to human chromosome 1 (Kingsmore et al., 1989) . Notably, the human genes, including the IFI 16 gene, are located in the 1q22 region, a region predicted to harbor genes with a role in cellular senescence (Hensler et al, 1994; Karlsson et al, 1996) . Consistent with this prediction, expression of the AIM2 gene is lost in human fibroblasts derived from Li-Fraumeni patients during their immortalization (Kulaeva et al, 2003) .
The protein IFI 16 (encoded by the IFI 16 gene) is a phosphoprotein (80-85 kDa), which contains two repeats of 200 amino acids (one a-type and one b-type) and a serine-threonine-proline (S/T/P)-rich spacer region separates the two repeats (Johnstone and Trapani, 1999) . The size of the spacer region in IFI 16 is regulated by mRNA splicing and can contain one, two, or three copies of highly conserved 56-amino-acid S/T/P domain encoded by distinct exons, resulting in three different size proteins: A, B, and C (Johnstone and Trapani, 1999) .
Increased expression levels of IFI 16 are associated with cellular senescence in human prostate epithelial cells (Xin et al., 2003) , a relatively less-characterized cell system with respect to cellular senescence. Therefore, to further examine the role of IFI 16 in cellular senescence, we chose to examine expression of IFI 16 in human diploid fibroblasts, cells that have been widely used to study cellular senescence.
Results

Levels of IFI 16 are higher in old versus young human fibroblasts
To examine a potential role for IFI 16 in cellular senescence of fibroblasts, we compared levels of IFI 16 in extracts derived from WI-38 fetal lung fibroblasts (passage 23; young) and WI-38 fibroblasts approaching cellular senescence (passage 58; old; 65-75% cells morphologically appearing large and positive for senescence-associated acidic b-galactosidase (SA-bgal)) ( Figure 1a ). As shown in Figure 1b , levels of IFI 16 were higher in extracts derived from old compared with young fibroblasts (compare lane 2 with lane 1). As reported previously (Ohtani et al., 2001) , levels of Id-1 protein, an inhibitor of cellular senescence (Alani et al., 2001; Sikder et al., 2003) , were lower in extracts derived from old fibroblasts than young fibroblasts. Additionally, semiquantitative RT-PCR for all three forms of IFI 16 mRNAs revealed that levels of IFI16 mRNA were relatively higher in old WI-38 fibroblasts than young fibroblasts (see Figure 1c , compare lane 1 with lane 2). This observation indicated that increases in the expression levels of IFI 16 protein in old WI-38 fibroblasts are, in part, due to the transcriptional mechanisms. Additionally, we also compared levels of IFI 16 protein between young and old BJ (also known as HCA2) neonatal human diploid foreskin fibroblasts. We found that levels of IFI 16 were significantly higher in old fibroblasts than young (data not shown).
Immortalization of fibroblasts is associated with reduced expression of IFI 16
Loss of IFI 16 expression or its cytoplasmic localization is associated with the development of cancer (Xin et al., 2003; Fujiuchi et al., 2004) . Because cancer cells have increased activity of telomerase (Kim et al., 1994; Cong et al., 2002) , we tested whether immortalization of WI-38 human diploid fibroblasts (HDFs) with the catalytic subunit of telomerase (hTERT) could affect the expression levels of IFI 16. We found that WI-38 (hTERT) 
Overexpression of IFI 16 in immortalized fibroblasts inhibits cell proliferation
Increased expression of IFI 16 in epithelial cells is associated with inhibition of cell proliferation (Xin et al., 2003; Raffaella et al., 2004) . Therefore, to further define 
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H Xin et al a role for IFI 16 in cellular senescence of fibroblasts, we chose to determine whether increased expression of IFI 16 in immortalized fibroblasts inhibits cell proliferation. As shown in Figure 3a , transfections of a plasmid encoding IFI 16B protein in hTERT immortalized BJ fibroblasts strongly (480%) inhibited colony formation as compared to vector-transfected cells. This observation is consistent with the possibility that increased levels of IFI 16 in HDFs limit cell proliferation. Because IFI 16-mediated inhibition of cell growth is associated with potentiation of p53-mediated transcription of the p21-luc-reporter and upregulation of p21 WAF1 levels (Xin et al., 2003; Raffaella et al., 2004) , we tested whether IFI 16 potentiates p53-medited transcription of p21-luc-reporter in fibroblasts. As shown in Figure 3b , transfection of immortalized BJ fibroblasts with low amounts (100 ng) of plasmid encoding p53 or IFI 16 did not result in significant stimulation of the activity of luciferase. However, transfection of cells with plasmids encoding both p53 and IFI 16 (in 1 : 1 ratio) resulted in significant stimulation of activity of the reporter. These observations indicated that IFI 16 potentiates p53-mediated transcription of p21
gene in fibroblasts.
Knockdown of IFI 16 expression in fibroblasts downregulates p21
WAF1 expression and inhibits p53-mediated transcription Increased expression of IFI 16 in normal epithelial cells is associated with inhibition of cell cycle progression and upregulation of p21 WAF1 (Xin et al., 2003; Raffaella et al., 2004) . Therefore, to further define a role for IFI 16 in cellular senescence of HDFs, we chose to knock down the expression of IFI 16 in WI-38 HDFs. We used small inhibitory RNA (si-RNA) approach to reduce the expression of IFI 16. As shown in Figure 4a , introduction of si-RNA IFI 16, but not equal amounts of si-RNA control, resulted in significant decreases in IFI 16 levels (compare lane 2 with lane 1). Moreover, the decrease was accompanied by increases in the levels of Id-1 protein and decreases in the levels of p21 WAF1 protein, but no change in p53 protein levels was detected (data not shown). However, knockdown of IFI 16 in WI-38 HDFs resulted in decreases in the transcriptional activity of p53, as indicated by decreases in the activities of two well-known p53-responsive reporters: the p21-luc and Gadd45-luc. These observations provided further support for our conclusion that increased levels of IFI 16 in older populations of normal fibroblasts upregulate p21 WAF1 levels, in part, by potentiating p53-mediated transcription of p21 WAF1/CIP1 gene.
Knockdown of IFI 16 expression in fibroblasts extends the lifespan
Next, we sought to determine whether knockdown of IFI 16 expression in fibroblasts extends the lifespan. Therefore, to knock down the expression of IFI 16 in fibroblasts for a long time, we repeatedly transfected cells with either si-RNA control or si-RNA IFI 16 (see Figure 5a ) and maintained cells in culture. As shown in Figure 5d ) in two independent experiments. Moreover, a careful analyses of cell proliferation revealed that cells expressing reduced levels of IFI 16 continued to proliferate even after more than 90% control cells ceased to proliferate (Figure 5e ). Taken together, these observations support the idea that reduced levels of IFI 16 in normal human fibroblasts extend the lifespan.
DNA methylation contributes to reduced expression of IFI 16 in immortalized fibroblasts
Immortalization of human diploid fibroblasts is associated with silencing of IFN-activatable genes by DNA 3) or after IFN-a treatment (1000 U/ml for 24 h; lanes 2 and 4). Extracts were analysed by immunoblotting using antibodies to IFI 16 or bactin. (c) Total cell extracts were prepared from WI-38 human fibroblasts (passage 23; lanes 1 and 2) or WI-38 fibroblasts transformed with SV40 virus (lanes 3 and 4) without any treatment (lanes 1 and 3) or after IFN-a treatment (1000 U/ml for 24 h; lanes 2 and 4). Extracts were analysed by immunoblotting using antibodies to IFI 16 or b-actin
Role of IFI 16 in cellular senescence H Xin et al methylation (Kulaeva et al, 2003) . Additionally, DNA methylation is shown to silence expression of IFI 16 in cancer (Fujiuchi et al., 2004 ). Therefore, we tested whether DNA methylation could affect the expression of IFI 16 in immortalized fibroblasts. As shown in Figure 6a , immortalized BJ (hTERT) cells expressed detectable levels of IFI 16. Moreover, treatment of cells with 5-aza-2 0 -deoxycytidine (5-AZA-dC), an inhibitor of DNA methyltransferase (DNMT), resulted in an B60-70% increase in the levels of IFI 16 (compare lane 3 with lane 1). Consistent with the previous report (Kulaeva et al., 2003) , levels of IFN-inducible proteins, such as STAT1, were also increased after treatment of cells with 5-AZA-dC. Similarly, treatment of a fibrosarcoma cell line (HT1080) and a prostate cancer cell line (DU-145) with the inhibitor also resulted in 2-3-fold upregulation of IFI 16 protein (data not shown). These observations indicated that DNA methylation reduces the expression of IFI 16 in immortalized cells.
Discussion
It has been proposed that in identifying candidate genes that are responsible for the initiation and/or main- Immortalized BJ fibroblasts were transfected with p21-luc-reporter and a second reporter (pRL-Tk; in 1 : 0.2 ratio) plasmid along with an empty plasmid pCDNA3 (column 1), pCDNA3-p53 (100 ng; column 2), pCDNA3-IFI 16B (100 ng; column 3), or both pCDNA3-p53 and pCDNA3-IFI 16B (100 ng each; column 4). The total amount of plasmid DNA was adjusted to equal amounts with pCDNA3 plasmid. At 40-45 h after transfections of cells, dual luciferase activity was determined as described in Materials and methods. Bars indicate standard deviation Our work (Xin et al., 2003) , using normal human prostate epithelial cells as a model system, has raised the possibility that IFI 16 gene (encoding IFI 16 protein) is a long sought gene on human chromosome 1 with role in cellular senescence. Our present work using human fibroblasts, a well-characterized cell model system for cellular senescence, revealed that (i) increased expression of IFI 16 inhibits cell proliferation ( Figure 3) ; (ii) knockdown of IFI 16 expression extends the proliferation potential ( Figure 5) ; (iii) immortalization of cells is associated with downregulation of IFI 16 expression ( Figures 2 and 6) ; and (iv) expression levels of IFI 16 are higher in old versus young cells (Figure 1 ). Taken together, our observations suggest that the IFI 16 gene meets all the criteria mentioned above for a senescenceregulating gene on human chromosome 1.
Immortalization of human fibroblasts with telomerase is shown to stabilize DNMT I activity, resulting in an inhibition of senescence-associated increases in the Our initial analysis has revealed that the 5 0 -regulatory region of IFI 16 does not contain CpG islands, identified in genes whose expression is silenced by direct DNA methylation. Therefore, it is likely that DNA methylation indirectly affects transcription of the IFI 16 gene. Consistent with this possibility, we found that treatment of immortalized human fibroblasts with 5AZA-dC resulted in significant increases in the levels of signal transducer and activator of transcription (STAT) (Figure 6 ). Importantly, the promoter region of the IFI 16 gene contains potential DNA-binding sites for the transcription factor STAT1. Further work will be needed to elucidate the molecular mechanisms by which DNA methylation reduces or silences the expression of IFI 16 in immortalized fibroblasts.
IFN signaling is known to inhibit telomerase activity and expression of hTERT gene . However, the particular IFN-inducible proteins inhibiting telomerase activity or the expression of hTERT remain to be identified. Our observation that knockdown of IFI 16 expression in normal human fibroblasts extends the proliferation potential raises the possibility that increased levels of IFN-inducible IFI 16 in older populations of fibroblasts contribute to cellular senescence, in part, by inhibiting the activity of telomerase and/or downregulating the expression of hTERT. Further work is in progress to test this interesting possibility.
Proteins encoded by Ifi200 gene family share at least one repeat of 200 amino acids, which appears to be important for protein-protein interactions (Choubey, 2000; Choubey and Kotzin, 2002) . Additionally, some proteins (including IFI 16) also contain a newly identified Pyrin/PAAD/DAPIN protein-protein interaction domain toward their N-terminus (Choubey and Kotzin, 2002; Asefa et al., 2004) . Based on the presence of protein-protein interaction domains, the p200 family proteins are thought to act as scaffolds to assemble protein complexes that regulate transcription of genes (Choubey and Kotzin, 2002; Xin et al., 2003) . Consistent with this role of p200 family proteins, p202, a relatively well-characterized member of the family (Choubey, 2000) , is known to bind and inhibit the transcriptional activity of several factors, such as c-Myc, p53, E2F, and AP-1. The protein p202 also binds to the pocket family proteins, such as pRb , and upregulates the expression of p21 WAF1 (Gutterman and Choubey, 1999) . The ability of p202 to inhibit cell cycle progression, in part, depends on its ability to act as a transcriptional regulator (Choubey and Kotzin, 2002) .
Consistent with a role as a scaffold protein, IFI 16 protein binds to p53 (Johnstone et al., 2000) , pRb (Xin et al, 2003) , E2F1 (Xin et al., 2003) , and BRCA1 (Aglipay et al., 2003) . Moreover, forced expression of IFI 16 in epithelial cells upregulates the expression of p53 (Raffaella et al., 2004) and p21 WAF1 (Xin et al., 2003; Raffaella et al., 2004) . Of note, IFI 16 increases p21 WAF1 levels, in part, by potentiating p53-mediated transcription of p21 WAF1 gene (Johnstone et al., 2000; Fujiuchi et al., 2004) . Therefore, our observations that knockdown of IFI 16 expression in human fibroblasts downregulates p21 WAF1 expression and inhibits p53-mediated transcription are consistent with the possibility that increased levels of IFI 16 in older populations of fibroblasts contribute to cellular senescence, in part, by potentiating p53-mediated transcription of p21 WAF1 gene. We have noted that ectopic expression of IFI 16 in cancer cell lines, which do not express functional p53, upregulates p21 WAF1 expression (Xin et al., 2003) . This observation suggests that IFI 16 can upregulate expression of p21 WAF1 independent of p53. Consistent with this possibility, we found that IFI 16 can bind to p73, a member of the p53 protein family (H Xin and D Choubey, unpublished data) . Therefore, it is conceivable that binding of IFI 16 to p73 contributes to p73-mediated transcription of p21 WAF1 gene. Mouse proteins, such as p202 and p204, from the p200 family are known to inhibit cell proliferation, in (Choubey, 2000) . Moreover, our recent observations have revealed that the protein IFI 16 binds to both Rb and E2F and forced expression of IFI 16 inhibits E2F-mediated transcription (Xin et al., 2003) . These observations support the hypothesis that IFI 16 contributes to senescenceassociated irreversible cell growth arrest by potentiating the Rb-E2F-mediated transcriptional repression of E2F-responsive genes. Id proteins have been implicated in the regulation of a variety of cellular processes, including cellular senescence (Sikder et al., 2003) . Increased expression of Id1 protein is shown to result in immortalization of cells (Alani et al., 1999) . Our observation that knockdown of IFI 16 in fibroblasts upregulates Id1 expression (Figure 4 ) raises the possibility that IFI 16 contributes to cellular senescence, in part, by downregulating the expression of Id1.
Most p200 family proteins, including IFI 16, contain a nuclear localization signal (NLS). Consistent with the presence of an NLS in IFI 16 protein, it is detected primarily in the nucleus of normal cells (Dawson and Trapani, 1995; Xin et al., 2003; Fujiuchi et al., 2004) . Interestingly, IFI 16 is detected primarily in the cytoplasm of some cancer cell lines and tumor tissues (Xin et al., 2003; Fujiuchi et al., 2004) , raising the possibility that the cytoplasmic localization of IFI 16 inactivates its nuclear function as a transcriptional regulator. Further work is needed to test this possibility.
Our observations described here provide support for our model (Figure 7 ) and predict that alterations in the expression of IFI 16 (or loss of IFI 16 function) may contribute to age-dependent diseases, including cancer.
Materials and methods
Human fibroblasts and immortalized cell lines
Normal human WI-38 fibroblasts (AG06814) and WI-38 fibroblasts transformed with SV40 virus (AG07217) were provided by Coriell Cell Repositories (Camden, NJ, USA). Immortalized WI-38 (hTERT) and BJ (hTERT) cell lines were very generously provided by Dr J Campisi (Lawrence Berkeley National Laboratory, Berkeley, CA, USA). Dr O PereiraSmith provided CMV-MJ-HeL1 (CMV) immortal cell line. Cells were maintained in DMEM culture medium supplemented with 10% fetal bovine serum and antibiotics. Cells were cultured in a cell culture incubator (CO 2 , 5%; Oxygen, 20%). Cultures of normal fibroblasts upon reaching confluence were split 1 : 4 ratio. Thus, each cell passage was equivalent to Btwo cell population doublings.
Plasmids and antibodies
Mammalian expression vector (pCMV-IFI 16B) to express IFI 16B protein and monoclonal antibodies to detect all three forms of IFI 16 have been described (Xin et al., 2003) . Antibodies to Id1 (sc-488), p53 (sc-99 and sc-6243), and p21 WAF1 (sc-6246) were purchased from Santa Cruz Biotech. Monoclonal antibodies to b-actin (A5441) were purchased from Sigma.
RT-PCR
Total RNA isolated from fibroblasts was subjected to one-step RT-PCR, using IFI 16B specific primers and a kit from Gibco-BRL, as suggested by the supplier.
Colony formation assays
Colony formation assays were performed essentially as described previously (Xin et al., 2003) . In brief, cells (10 5 cells in a 60-mm plate) were transfected with either empty vector (pCDNA3; 2 mg) or equal amounts of pCDNA3-IFI 16B plasmid (encoding IFI 16B protein) using FuGENE 6 transfection agent. Following 24 h of transfections, cells were split into two 100-mm plates and selected in G418 for about 2 weeks. Colonies exhibiting G418 resistance were stained with crystal violet and counted as described previously (Xin et al., 2003) .
Knockdown of IFI 16 expression
We have optimized conditions to knock down expression of IFI 16 in human WI-38 fibroblasts. We used the RNAifect kit (from Qiagen Inc.) to transfect IFI 16 si-RNA or control si-RNA (Silencer TM Negative Control # 1, Ambion, San Antonio, TX, USA) in subconfluent WI-38 cells, resulting in 470% decrease in endogenous levels of IFI 16 protein.
The target DNA sequence for si-RNA IFI 16 has been described previously . We noted that the knockdown of IFI 16 expression was relatively less (B50%) in older populations of WI-38 cells than the young populations.
Reporter assays
Luciferase reporter assays were performed as described previously (Xin et al., 2003) . In brief, subconfluent cultures of fibroblasts were transfected using FuGENE 6 transfection reagent (Rosch, Indianapolis, IN, USA) with desired p-lucreporter plasmid (1 mg) and a second reporter pRL-TK (0.1 mg; encoding the Renilla luciferase) with appropriate amounts of plasmid encoding the gene of interest. The cells were harvested 45 h after transfections and the firefly luciferase and Renilla luciferase activities were determined (in triplicate) using the Dual-Luciferase Reporter Assay kit (from Promega). The firefly luciferase activity was normalized to Renilla luciferase in order to control for variations in transfections. The luciferase activity in control vector-transfected cells was considered as 1. Standard error was calculated using three experimental readings.
Immunoblotting
To prepare cell lysates, fibroblasts were collected from plates in PBS and resuspended in a modified RIPA lysis buffer (50 mM Tris-HCl (pH 8.0), 250 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitors (leupeptin, 50 mg/ml; pepstatin A, 50 mg/ml; PMSF, 1 mM), and incubated at 41C for 30 min. The cell lysates were sonicated briefly before centrifugation at 14 000 rpm in a microfuge for 10 min. The supernatants were collected and equal amounts of proteins were processed for immunoblotting as described previously (Xin et al., 2003) .
Senescence-associated b-galactosidase assays
These assays were performed essentially as described previously (Dimri et al., 1995) . In brief, cells in culture were fixed using the in situ b-galactosidase staining kit (cat. # 200384; Stratagene, La Jolla, CA, USA). Fixed cells were incubated with the staining solution prepared in a buffer (pH 6.0) overnight at 371C. Cells, which stained blue, were considered positive for the activity of SA-b-gal and were counted.
Cell proliferation
Cells were seeded in a 24-well plate in growth medium and cells were counted (in triplicate) on the indicated days using a hemocytometer.
